| CYTEGRITY CSL BEHRING GENE THERAPY INC.
2332384 14 Feb 2024 | on 12 Jun 2024 | Class 040 Class 040 Treatment & Processing of Materials Services Biomanufacturing for others, namely, manufacturing of pharmaceuticals and of viral vectors and gene therapy vectors; custom manufacturing services of ex vivo, lentiviral stable cell lines; custom manufacturing services of lentiviral vectors by transient transfection; biomanufacturing of viral vectors and gene therapy vectors; biomanufacturing services of cell lines and cells; biomanufacturing of biological preparations. Class 042 Class 042 Computer & Software Services & Scientific Services Scientific, pharmaceutical and medical research and development; biological research; laboratory services in connection with viral vectors and gene therapy vectors; scientific, pharmaceutical, and medical research platform services featuring bioproduction, regulatory pathway services, accessory proteins and alternative envelope proteins. Class 045 Personal & Legal & Social Services Regulatory and process pathway consulting for clinical manufacturing. | | | CYTEGRITY CSL BEHRING GENE THERAPY INC.
2331070 13 Feb 2024 | on 05 Jun 2024 | Class 001 Class 001 Chemical Products Cell lines for scientific and research use; Cells for scientific, laboratory or medical research; Biological preparations, namely, viral vectors and gene vectors for scientific, laboratory or medical research; Cell lines; cell lines for gene expression, and for synthesis of biological compounds; cells for gene expression and for synthesis of biological compounds; viral vectors. Class 005 Class 005 Pharmaceutical Products Cell lines for medical purposes; Cells for medical or clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating cancer, tumors, genetic diseases, immunodeficiency conditions, stem cell transplantation, and transplant medicine; Biological preparations, namely, viral vectors and gene therapy vectors for therapeutic use and clinical use; Biological preparations, namely, viral vectors and gene therapy vectors for treating a wide range of diseases, illnesses or conditions; Cell lines for medical purposes, namely, cell therapy; Cell lines for medical purposes, namely, immunotherapy; Cell lines for medical purposes, namely, for use as therapeutics to repair, replace or preserve cells and tissues; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating genetically engineered tissues and for treating transplant conditions; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating viral and infectious diseases; Biological preparations, namely, viral vectors and gene therapy vectors for medical or clinical use for treating metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological and immune system related diseases and disorders; viral vectors for gene therapy; gene therapy vectors. | |